Подписаться
Petar Scepanovic
Petar Scepanovic
Senior Scientist, Roche
Подтвержден адрес электронной почты в домене roche.com
Название
Процитировано
Процитировано
Год
Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
E Patin, M Hasan, J Bergstedt, V Rouilly, V Libri, A Urrutia, C Alanio, ...
Nature immunology 19 (3), 302-314, 2018
2612018
Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines
P Scepanovic, C Alanio, C Hammer, F Hodel, J Bergstedt, E Patin, ...
Genome medicine 10, 1-13, 2018
1432018
A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals
P Scepanovic, F Hodel, S Mondot, V Partula, A Byrd, C Hammer, C Alanio, ...
Microbiome 7 (1), 130, 2019
129*2019
The SIB Swiss Institute of Bioinformatics’ resources: focus on curated databases
SIB Swiss Institute of Bioinformatics Members
Nucleic acids research 44 (D1), D27-D37, 2016
512016
Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases
SC Ritchie, SA Lambert, M Arnold, SM Teo, S Lim, P Scepanovic, ...
Nature metabolism 3 (11), 1476-1483, 2021
502021
Human genomics of the humoral immune response against polyomaviruses
F Hodel, AY Chong, P Scepanovic, ZM Xu, O Naret, CW Thorball, ...
Virus evolution 7 (2), veab058, 2021
132021
Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients
S Asgari, N Chaturvedi, P Scepanovic, C Hammer, N Semmo, E Giostra, ...
Journal of viral hepatitis 26 (2), 271-277, 2019
62019
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes
D Morena, N Maestro, F Bersani, PE Forni, MF Lingua, V Foglizzo, ...
Elife 5, e12116, 2016
52016
P805 Selnoflast, a potent NLRP3 inhibitor-results from a phase 1b experimental medicine study in patients with Ulcerative Colitis
B Klughammer, L Piali, AC Nica, S Nagel, L Bailey, C Jochum, ...
Journal of Crohn's and Colitis 17 (Supplement_1), i938-i938, 2023
32023
A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate …
B Klughammer, L Piali, A Nica, S Nagel, L Bailey, C Jochum, S Ignatenko, ...
Clinical and Translational Medicine 13 (11), e1471, 2023
22023
Gut Microbiota Is Associated with Onset and Severity of Type 1 Diabetes in Nonobese Diabetic Mice Treated with Anti–PD-1
S Patel, E Becker, C Ploix, G Steiner, P Scepanovic, M Fueth, ...
ImmunoHorizons 7 (12), 872-885, 2023
2023
Genetic determinants of healthy human immune variance: from humoral response to microbiome diversity
P Scepanovic
EPFL, 2018
2018
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–12